AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21300712 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular Health Awareness Program (CHAP)
Number of subjects: 15
Study 19271065 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion (Group P)
Number of subjects: 30
Study 19271065 — intervention group
Group type: COMPARATOR
Intervention: Desflurane inhalation (Group D)
Number of subjects: 30
Study 16548950 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Tube-Suction Airway (LTS)
Number of subjects: 36
Study 16548950 — intervention group
Group type: COMPARATOR
Intervention: ProSeal Laryngeal Mask Airway (PLMA)
Number of subjects: 36
Study 12765890 — intervention group
Group type: EXPERIMENTAL
Intervention: parecoxib 40 mg i.v.
Number of subjects: 48
Study 12765890 — intervention group
Group type: COMPARATOR
Intervention: placebo (normal saline)
Number of subjects: 48
Study 10867454 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple closure with postsurgery medical treatment (proton pump inhibitors for 1 month)
Number of subjects: 207
Study 10867454 — intervention group
Group type: COMPARATOR
Intervention: Vagotomy and pyloroplasty with no additional medical treatment
Number of subjects: 207
Study 9089001 — intervention group
Group type: EXPERIMENTAL
Intervention: Demotussol Hustensirup (syrup)
Number of subjects: 18
Study 9089001 — intervention group
Group type: COMPARATOR
Intervention: Sinecod Sirup (syrup)
Number of subjects: 18
Study 9089001 — intervention group
Group type: EXPERIMENTAL
Intervention: Demotussol Tabletten (tablet)
Number of subjects: 18
Study 9089001 — intervention group
Group type: COMPARATOR
Intervention: Demotussol Hustentropfen (solution)
Number of subjects: 18
Study 8404115 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking intervention with daily use of a metered-dose inhaler with ipratropium bromide
Number of subjects: 5887
Study 8404115 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking intervention with inhalation of placebo
Number of subjects: 5887
Study 8404115 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5887
Study 8404115 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 5887
Study 2957569 — intervention group
Group type: EXPERIMENTAL
Intervention: Org OD 14 (2 micrograms/day/rat for 14 days)
Number of subjects: 9
Study 2957569 — intervention group
Group type: EXPERIMENTAL
Intervention: Org OD 14 (10 micrograms/day/rat for 14 days)
Number of subjects: 9
Study 2957569 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestradiol benzoate (10 micrograms/day/rat for 14 days)
Number of subjects: 9
Study 2957569 — intervention group
Group type: EXPERIMENTAL
Intervention: Org OD 14 (2.5 mg/day for 6 months)
Number of subjects: 9
Study 2957569 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 29724172 — intervention group
Group type: EXPERIMENTAL
Intervention: Paramedic-delivered Care Transitions Intervention (CTI) consisting of one home visit and up to three follow-up phone calls.
Number of subjects: 2400
Study 29724172 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care without the CTI).
Number of subjects: 2400
Study 28306636 — intervention group
Group type: EXPERIMENTAL
Intervention: perindopril/indapamide/amlodipine 5/1.25/5 mg
Number of subjects: 454
Study 28306636 — intervention group
Group type: EXPERIMENTAL
Intervention: perindopril/indapamide/amlodipine 10/2.5/10 mg (up-titration)
Number of subjects: 454
Study 28306636 — intervention group
Group type: COMPARATOR
Intervention: perindopril/indapamide 5/1.25 mg
Number of subjects: 454
Study 28306636 — intervention group
Group type: EXPERIMENTAL
Intervention: ABPM
Number of subjects: 454
Study 28306636 — intervention group
Group type: EXPERIMENTAL
Intervention: HBPM
Number of subjects: 454
Study 25675176 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine butylbromide use
Number of subjects: 118
Study 25675176 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenoma Detection Rate (ADR)
Number of subjects: 118
Study 25675176 — intervention group
Group type: EXPERIMENTAL
Intervention: ADR in lower two quartiles
Number of subjects: 118
Study 25675176 — intervention group
Group type: EXPERIMENTAL
Intervention: ADR in upper middle quartile
Number of subjects: 118
Study 25675176 — intervention group
Group type: EXPERIMENTAL
Intervention: ADR in upper quartile
Number of subjects: 118
Study 23059198 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM) present
Number of subjects: 4133
Study 23059198 — intervention group
Group type: COMPARATOR
Intervention: No Diabetes Mellitus (DM)
Number of subjects: 4133
Study 23059198 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic control strategy
Number of subjects: 4133
Study 19779804 — intervention group
Group type: EXPERIMENTAL
Intervention: DASI trained physicians (n = 32)
Number of subjects: 62
Study 19779804 — intervention group
Group type: COMPARATOR
Intervention: Control group physicians (n = 30)
Number of subjects: 62
Study 18220456 — intervention group
Group type: EXPERIMENTAL
Intervention: School nursing service
Number of subjects: 104
Study 18220456 — intervention group
Group type: COMPARATOR
Intervention: Control group (no school nursing service)
Number of subjects: 104
Study 21504973 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscadine grape seed supplementation (1300 mg daily)
Number of subjects: 50
Study 21504973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 15888038 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid avoidance regimen (no steroids at all)
Number of subjects: 50
Study 15888038 — intervention group
Group type: COMPARATOR
Intervention: Steroid withdrawal regimen (steroids for the first 3 months)
Number of subjects: 50
Study 15888038 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 50
Study 12218418 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 10
Study 12218418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 9758395 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuji Bond LC (FB)
Number of subjects: 96
Study 9758395 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisco One‐step (BC)
Number of subjects: 96
Study 9758395 — intervention group
Group type: COMPARATOR
Intervention: Scotchbond Multi‐purpose (SB)
Number of subjects: 96
Study 9758395 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond 2.0 (PB)
Number of subjects: 96
Study 7851224 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week self-management education program
Number of subjects: 24
Study 7851224 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 24
Study 3134629 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 60
Study 31987528 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 30
Study 31987528 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 30
Study 31987528 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 30
Study 31987528 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 30
Study 30284018 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 0
Study 30284018 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 0
Study 27214389 — intervention group
Group type: EXPERIMENTAL
Intervention: Glatiramer acetate treatment
Number of subjects: 64
Study 27020837 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl sublingual spray (FSS) effective dose (100-1600 µg)
Number of subjects: 50
Study 24615047 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C9*3 variant genotypes
Number of subjects: 24
Study 24615047 — intervention group
Group type: COMPARATOR
Intervention: Wild type genotype
Number of subjects: 24
Study 23035730 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream
Number of subjects: 183
Study 23035730 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 183
Study 19650674 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP/F 400 microg/24 microg (four inhalations of Foster BDP/F 100 microg/6 microg)
Number of subjects: 12
Study 19650674 — intervention group
Group type: COMPARATOR
Intervention: BDP CFC 1000 microg (four inhalations of Becotide Forte 250 microg) plus formoterol 24 microg (four inhalations of Atimos 6 microg)
Number of subjects: 12
Study 19650674 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 17381944 — intervention group
Group type: EXPERIMENTAL
Intervention: Free F&V distribution programme
Number of subjects: 939
Study 17381944 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent programme (classroom curriculum and parental involvement)
Number of subjects: 939
Study 17381944 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 939
Study 15479896 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg oral prednisolone/day for three weeks
Number of subjects: 50
Study 15479896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 11175236 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemically-heated HME (Thermax HCH Filter)
Number of subjects: 50
Study 11175236 — intervention group
Group type: COMPARATOR
Intervention: Conventional HME (Humid-Vent 1)
Number of subjects: 50
Study 11175236 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 50
Study 9747640 — intervention group
Group type: EXPERIMENTAL
Intervention: Pituitary irradiation for diabetic retinopathy
Number of subjects: 167
Study 9747640 — intervention group
Group type: COMPARATOR
Intervention: Control group (WESDR)
Number of subjects: 167
Study 7530437 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of alpha fetoprotein and free beta human chorionic gonadotropin
Number of subjects: 0
Study 7530437 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconjugated oestriol and pregnancy associated plasma protein A
Number of subjects: 0
Study 7530437 — intervention group
Group type: EXPERIMENTAL
Intervention: First trimester screening
Number of subjects: 0
Study 2902114 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocabastine (0.5 mg/ml, one drop twice a day)
Number of subjects: 11
Study 2902114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 2902114 — intervention group
Group type: COMPARATOR
Intervention: Screening test (no medication)
Number of subjects: 11
Study 2902114 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocabastine
Number of subjects: 11
Study 29379143 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 224
Study 29379143 — intervention group
Group type: EXPERIMENTAL
Intervention: White wine
Number of subjects: 224
Study 29379143 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 224
Study 29379143 — intervention group
Group type: EXPERIMENTAL
Intervention: Wine (combined)
Number of subjects: 224
Study 27784379 — intervention group
Group type: EXPERIMENTAL
Intervention: decitabine + HAG pre‐excitation regimen
Number of subjects: 50
Study 27784379 — intervention group
Group type: COMPARATOR
Intervention: '3+7' regimen
Number of subjects: 50
Study 25322606 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 microg/kg) over 15 minutes
Number of subjects: 44
Study 25322606 — intervention group
Group type: COMPARATOR
Intervention: Propofol (2 mg/kg) intravenous injection
Number of subjects: 44
Study 25322606 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Dexmedetomidine and Propofol)
Number of subjects: 44
Study 23464842 — intervention group
Group type: EXPERIMENTAL
Intervention: Low stress condition (n=20)
Number of subjects: 41
Study 23464842 — intervention group
Group type: COMPARATOR
Intervention: High stress condition (n=21)
Number of subjects: 41
Study 20428741 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol (400 ug)
Number of subjects: 200
Study 20428741 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular oxytocin (10 IU)
Number of subjects: 200
Study 18275768 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose corticosteroids and immunosuppressive drugs (cyclophosphamide)
Number of subjects: 0
Study 18275768 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Number of subjects: 0
Study 18275768 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 0
Study 15842575 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg
Number of subjects: 794
Study 15842575 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 794
Study 15842575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 794
Study 12136891 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom manufactured rigid foot orthoses under podiatry supervision
Number of subjects: 98
Study 12136891 — intervention group
Group type: COMPARATOR
Intervention: Control group (foot orthoses prescribed under normal medical care)
Number of subjects: 98
Study 10544862 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein-based formula (SOY)
Number of subjects: 213
Study 10544862 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein-based formula with added nucleotide (SOYN)
Number of subjects: 213
Study 10544862 — intervention group
Group type: COMPARATOR
Intervention: Mixed feeding (MF)
Number of subjects: 213
Study 7837822 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational memorandum alone or combined with feedback regarding individual prescribing behavior
Number of subjects: 63
Study 2123115 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.75 mg leuprorelin
Number of subjects: 12
Study 2123115 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg leuprorelin
Number of subjects: 12
Study 872745 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary multiple enterostomies
Number of subjects: 30
Study 872745 — intervention group
Group type: COMPARATOR
Intervention: Proctocolectomy in one stage
Number of subjects: 30
Study 30964852 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient noise level 60 dB
Number of subjects: 0
Study 30964852 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient noise level 75 dB
Number of subjects: 0
Study 30964852 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient noise level 80 dB
Number of subjects: 0
Study 30964852 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent intubation attempts
Number of subjects: 0
Study 30964852 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological heart rate monitoring
Number of subjects: 0
Study 30652777 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Group Intervention (BGI) with four group sessions, weekly meetings
Number of subjects: 180
Study 30652777 — intervention group
Group type: COMPARATOR
Intervention: Information leaflet about alcohol consumption
Number of subjects: 180
Study 27679533 — intervention group
Group type: EXPERIMENTAL
Intervention: FAST‐MAG clinical trial (Field Administration of Stroke Therapy‐Magnesium)
Number of subjects: 490
Study 27679533 — intervention group
Group type: EXPERIMENTAL
Intervention: Very elderly population
Number of subjects: 490
Study 24523488 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-dilution protocol
Number of subjects: 0
Study 24523488 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-retest protocol
Number of subjects: 0
Study 24523488 — intervention group
Group type: EXPERIMENTAL
Intervention: Doubly labeled water (DLW) method
Number of subjects: 0
Study 22264468 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle weight loss intervention
Number of subjects: 2739
Study 22264468 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education
Number of subjects: 2739
Study 22264468 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss (each kg lost)
Number of subjects: 2739
Study 22264468 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss (5% to 10%)
Number of subjects: 2739
Study 20859046 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinyl bags used for resuscitation
Number of subjects: 60
Study 20859046 — intervention group
Group type: COMPARATOR
Intervention: Conventional drying under radiant warmer (Control)
Number of subjects: 60
Study 18180167 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveyed after consultation with specially trained midwives
Number of subjects: 300
Study 18180167 — intervention group
Group type: COMPARATOR
Intervention: Surveyed before consultation with specially trained midwives
Number of subjects: 300
Study 15860237 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (n=13)
Number of subjects: 27
Study 15860237 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide (n=14)
Number of subjects: 27
Study 14564193 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased dose of peritoneal small molecule clearance delivered by chronic ambulatory peritoneal dialysis
Number of subjects: 0
Study 14564193 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical assessment of dialysis adequacy, preservation of residual renal function, and optimization of salt and water removal
Number of subjects: 0
Study 10828859 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy and autologous stem cell transplantation
Number of subjects: 0
Study 10828859 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 9058342 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg itraconazole (one-day monthly prophylaxis for six months)
Number of subjects: 57
Study 9058342 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 57
Study 8375881 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (40 mg elemental iron/day) for six months
Number of subjects: 170
Study 8375881 — intervention group
Group type: COMPARATOR
Intervention: Sugar placebo
Number of subjects: 170
Study 3091138 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestrogen (160 mg polyestradiol phosphate intramuscularly every month for the first three months, then 80 mg monthly, plus ethinyloestradiol 1 mg by mouth daily for the first two weeks, then 150 micrograms daily)
Number of subjects: 100
Study 3091138 — intervention group
Group type: COMPARATOR
Intervention: Orchidectomy
Number of subjects: 100
Study 29703446 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism adaptation plus methylphenidate (MP)
Number of subjects: 24
Study 29703446 — intervention group
Group type: COMPARATOR
Intervention: Prism adaptation plus placebo
Number of subjects: 24
Study 26318636 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D‐LPNSSAC
Number of subjects: 90
Study 26318636 — intervention group
Group type: COMPARATOR
Intervention: 2D‐LPN
Number of subjects: 90
Study 26318636 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study 25066223 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT + treatment as usual (TAU)
Number of subjects: 154
Study 25066223 — intervention group
Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 154
Study 25066223 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT + TAU
Number of subjects: 154
Study 22762533 — intervention group
Group type: EXPERIMENTAL
Intervention: Any bleeding during the first 20 weeks of pregnancy
Number of subjects: 3431
Study 22762533 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleeding episode of five or more consecutive days
Number of subjects: 3431
Study 22762533 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple episodes of bleeding
Number of subjects: 3431
Study 19939373 — intervention group
Group type: EXPERIMENTAL
Intervention: High hyaluronic acid (HA) transfer medium, n = 199
Number of subjects: 425
Study 19939373 — intervention group
Group type: COMPARATOR
Intervention: Low hyaluronic acid (HA) transfer medium, n = 226
Number of subjects: 425
Study 18540734 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for pain (P)
Number of subjects: 144
Study 18540734 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation and emotion regulation therapy (M)
Number of subjects: 144
Study 18540734 — intervention group
Group type: COMPARATOR
Intervention: Education-only group (E)
Number of subjects: 144
Study 15846228 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized estradiol (E2) 1 mg/day
Number of subjects: 132
Study 15846228 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 1 mg/day + MPA 10 mg/day
Number of subjects: 132
Study 15846228 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 10 mg/day
Number of subjects: 132
Study 15846228 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized progesterone (P4) 300 mg/day
Number of subjects: 132
Study 15846228 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethindrone (NET) 1 mg/day
Number of subjects: 132
Study 15846228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 15846228 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation (1000 mg of calcium and 400 IU of vitamin D/day)
Number of subjects: 132
Study 11427217 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol (50 mg/day)
Number of subjects: 29133
Study 11427217 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene (20 mg/day)
Number of subjects: 29133
Study 11427217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29133
Study 9517683 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine-phenylephrine
Number of subjects: 180
Study 9517683 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine-phenylephrine
Number of subjects: 180
Study 9517683 — intervention group
Group type: COMPARATOR
Intervention: Tetracaine-adrenaline-cocaine (TAC)
Number of subjects: 180
Study 7752832 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ) therapy
Number of subjects: 20
Study 7752832 — intervention group
Group type: COMPARATOR
Intervention: Anthracyclines (ANT) without CoQ therapy
Number of subjects: 20
Study 3281412 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg daily for the first 3 months
Number of subjects: 1395
Study 3281412 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for the first 3 months
Number of subjects: 1395
Study 3281412 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (early treatment, ≤ 8 hours after onset of pain)
Number of subjects: 1395